ASX - By Stock
|
NVX |
Re:
Ann: Market Update
|
|
lidcombe
|
58 |
20K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
58
|
20K
|
0
|
|
ASX - By Stock
|
GAL |
Re:
Ann: Mineral Resources Lithium Joint Venture Agreement
|
|
lidcombe
|
13 |
10K |
0 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
13
|
10K
|
0
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Responses to ASX Letters
|
|
lidcombe
|
109 |
32K |
4 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
109
|
32K
|
4
|
|
ASX - By Stock
|
MVP |
Re:
Share price has doubled, no announcements
|
|
lidcombe
|
85 |
35K |
5 |
23/07/23 |
23/07/23 |
ASX - By Stock
|
85
|
35K
|
5
|
|
ASX - By Stock
|
SP1 |
Re:
FY2022 annual report
|
|
lidcombe
|
15 |
7.0K |
7 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
15
|
7.0K
|
7
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Completion of Drilling Programme at Corella Graphite
|
|
lidcombe
|
19 |
4.9K |
1 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
19
|
4.9K
|
1
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Arafura signs binding offtake agreement with Hyundai and Kia
|
|
lidcombe
|
79 |
41K |
2 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
79
|
41K
|
2
|
|
ASX - By Stock
|
NVX |
Re:
News: NVX Novonix Selected For Us$150 Million Grant From U.S. Department Of Energy
|
|
lidcombe
|
40 |
20K |
1 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
40
|
20K
|
1
|
|
ASX - By Stock
|
WSA |
Re:
Ann: Trading Halt
|
|
lidcombe
|
6 |
2.7K |
3 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
6
|
2.7K
|
3
|
|
ASX - By Stock
|
ARU |
Re:
Predictions Regarding the Russian Invasion and ARU's SP/demand
|
|
lidcombe
|
12 |
6.8K |
5 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
12
|
6.8K
|
5
|
|
ASX - By Stock
|
LTR |
Re:
Macquarie target up 18% to A$2.00 - Bell Potter up 61.6% to A$2.15
|
|
lidcombe
|
5 |
3.2K |
7 |
14/11/21 |
14/11/21 |
ASX - By Stock
|
5
|
3.2K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene completes $90 M placement and launches $5 M SPP
|
|
lidcombe
|
477 |
222K |
4 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
477
|
222K
|
4
|
|
ASX - By Stock
|
MVP |
Re:
Has MVP Bottomed Out With The Change In Market Sentiment?
|
|
lidcombe
|
60 |
34K |
0 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
60
|
34K
|
0
|
|
ASX - By Stock
|
ALU |
Re:
Ann: Pause in Trading
|
|
lidcombe
|
27 |
13K |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
27
|
13K
|
0
|
|
ASX - By Stock
|
ALU |
Re:
Ann: Pause in Trading
|
|
lidcombe
|
27 |
13K |
0 |
19/07/21 |
19/07/21 |
ASX - By Stock
|
27
|
13K
|
0
|
|
ASX - By Stock
|
LTR |
Re:
LTR vs LSA
|
|
lidcombe
|
22 |
10K |
18 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
22
|
10K
|
18
|
|
ASX - By Stock
|
CHN |
Re:
Ann: Extensive Ni-Cu Soil Anomalism at Julimar
|
|
lidcombe
|
231 |
106K |
0 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
231
|
106K
|
0
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Trading Halt
|
|
lidcombe
|
129 |
69K |
0 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
129
|
69K
|
0
|
|
ASX - By Stock
|
MNS |
Re:
Ann: Trading Halt
|
|
lidcombe
|
129 |
69K |
4 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
129
|
69K
|
4
|
|
ASX - By Stock
|
MVP |
Re:
Ann: MVP Roadshow Presentation
|
|
lidcombe
|
15 |
7.7K |
1 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
15
|
7.7K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Ann: MVP Roadshow Presentation
|
|
lidcombe
|
15 |
7.7K |
3 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
15
|
7.7K
|
3
|
|
ASX - By Stock
|
ASM |
Re:
Morrison 10 year plan on rare earth
|
|
lidcombe
|
40 |
16K |
0 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
40
|
16K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
$1 Billion Long Term
|
|
lidcombe
|
12 |
5.9K |
1 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
12
|
5.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
lidcombe
|
4.4K |
2.0M |
0 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
lidcombe
|
4.4K |
2.0M |
2 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
lidcombe
|
4.4K |
2.0M |
3 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
4.4K
|
2.0M
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Pause in Trading
|
|
lidcombe
|
47 |
19K |
4 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
47
|
19K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro Receives Australian Market Approval
|
|
lidcombe
|
16 |
5.7K |
3 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
16
|
5.7K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro Completes Pivotal Step in TGA Approval Process
|
|
lidcombe
|
15 |
4.3K |
3 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
15
|
4.3K
|
3
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Trading Halt
|
|
lidcombe
|
35 |
14K |
0 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Trading Halt
|
|
lidcombe
|
35 |
14K |
2 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
lidcombe
|
56 |
22K |
6 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
56
|
22K
|
6
|
|
IPOs
|
Biotech |
Re:
Chimeric therapeutics
|
|
lidcombe
|
40 |
19K |
1 |
14/11/20 |
14/11/20 |
IPOs
|
40
|
19K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Annual Report to shareholders
|
|
lidcombe
|
2 |
1.7K |
2 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
2
|
1.7K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Alliance for cell therapy now - Sep 16
|
|
lidcombe
|
5 |
1.8K |
3 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
5
|
1.8K
|
3
|
|
ASX - By Stock
|
MVP |
Re:
Yet another favorable report
|
|
lidcombe
|
46 |
24K |
0 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Ann: MVP Roadshow Presentation
|
|
lidcombe
|
16 |
5.3K |
2 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
16
|
5.3K
|
2
|
|
ASX - By Stock
|
NAN |
Re:
Ann: 2020 Full Year Results
|
|
lidcombe
|
69 |
33K |
1 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
69
|
33K
|
1
|
|
ASX - By Stock
|
NAN |
Re:
Ann: 2020 Full Year Results
|
|
lidcombe
|
69 |
33K |
0 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
69
|
33K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
lidcombe
|
2.0K |
699K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
699K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Anyone else buy in after todays dip/crash?
|
|
lidcombe
|
211 |
88K |
0 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
211
|
88K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients
|
|
lidcombe
|
311 |
167K |
0 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
311
|
167K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Trading Halt
|
|
lidcombe
|
202 |
106K |
1 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
202
|
106K
|
1
|
|